MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

Search

STAAR Surgical Co

Ouvert

SecteurSoins de santé

27.25

Résumé

Variation du prix de l'action

24h

Actuel

Min

27.18

Max

27.47

Chiffres clés

By Trading Economics

Revenu

37M

-17M

Ventes

1.7M

44M

Marge bénéficiaire

-37.933

Employés

1,157

EBITDA

48M

-23M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

-3.13% downside

Dividendes

By Dow Jones

Prochains Résultats

29 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

409M

1.3B

Ouverture précédente

27.25

Clôture précédente

27.25

Sentiment de l'Actualité

By Acuity

67%

33%

334 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

STAAR Surgical Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 sept. 2025, 23:07 UTC

Acquisitions, Fusions, Rachats

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

5 août 2025, 10:10 UTC

Acquisitions, Fusions, Rachats

Alcon to Buy Staar Surgical for $1.5 Billion

26 sept. 2025, 21:56 UTC

Acquisitions, Fusions, Rachats

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

22 sept. 2025, 11:15 UTC

Acquisitions, Fusions, Rachats

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

16 sept. 2025, 13:12 UTC

Acquisitions, Fusions, Rachats

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16 sept. 2025, 13:12 UTC

Acquisitions, Fusions, Rachats

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16 sept. 2025, 13:11 UTC

Acquisitions, Fusions, Rachats

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16 sept. 2025, 13:10 UTC

Acquisitions, Fusions, Rachats

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

8 août 2025, 13:40 UTC

Market Talk
Acquisitions, Fusions, Rachats

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 août 2025, 05:07 UTC

Acquisitions, Fusions, Rachats

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 août 2025, 05:07 UTC

Acquisitions, Fusions, Rachats

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 août 2025, 05:07 UTC

Acquisitions, Fusions, Rachats

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 août 2025, 05:07 UTC

Acquisitions, Fusions, Rachats

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 août 2025, 05:01 UTC

Acquisitions, Fusions, Rachats

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

Comparaison

Variation de prix

STAAR Surgical Co prévision

Objectif de Prix

By TipRanks

-3.13% baisse

Prévisions sur 12 Mois

Moyen 26.33 USD  -3.13%

Haut 28 USD

Bas 18 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

0

Achat

8

Maintien

0

Vente

Score Technique

By Trading Central

18.604 / 20.07Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Very Strong Bullish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

334 / 371Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat